Suntrust Banks’s Novartis NVS Stock Holding History

Suntrust Banks’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$26.4M	Buy	303,719 +237,814	+361%	+$21.4M	0.14%	132
2019 Q2	$6.02M	Sell	65,905 -7,264	-10%	-$615K	0.03%	319
2019 Q1	$6.3M	Buy	73,169 +11,961	+20%	+$960K	0.03%	302
2018 Q4	$4.71M	Buy	61,208 +18,127	+42%	+$1.41M	0.03%	321
2018 Q3	$3.33M	Buy	43,081 +10,695	+33%	+$791K	0.02%	415
2018 Q2	$2.19M	Sell	32,386 -3,434	-10%	-$237K	0.01%	526
2018 Q1	$2.6M	Sell	35,820 -1,249	-3%	-$95.1K	0.01%	455
2017 Q4	$2.79M	Sell	37,069 -6,086	-14%	-$459K	0.02%	419
2017 Q3	$3.32M	Buy	43,155 +6,030	+16%	+$455K	0.02%	381
2017 Q2	$2.78M	Sell	37,125 -161,333	-81%	-$11.4M	0.02%	406
2017 Q1	$13.2M	Buy	198,458 +29,590	+18%	+$1.97M	0.08%	178
2016 Q4	$11M	Buy	168,868 +109,837	+186%	+$7.13M	0.07%	199
2016 Q3	$4.17M	Buy	59,031 +233	+0.4%	+$17K	0.03%	321
2016 Q2	$4.34M	Sell	58,798 -25,308	-30%	-$1.75M	0.03%	307
2016 Q1	$5.46M	Sell	84,106 -15,111	-15%	-$1.03M	0.03%	256
2015 Q4	$7.65M	Sell	99,217 -2	-0%	-$159	0.05%	216
2015 Q3	$8.17M	Buy	99,219 +6,647	+7%	+$592K	0.06%	206
2015 Q2	$8.16M	Buy	92,572 +9,699	+12%	+$890K	0.05%	208
2015 Q1	$7.32M	Buy	82,873 +4,628	+6%	+$411K	0.05%	216
2014 Q4	$6.49M	Sell	78,245 -25,100	-24%	-$2.08M	0.04%	217
2014 Q3	$8.71M	Sell	103,345 -19,113	-16%	-$1.55M	0.06%	189
2014 Q2	$9.93M	Sell	122,458 -24,125	-16%	-$1.9M	0.07%	184
2014 Q1	$11.2M	Sell	146,583 -2,097	-1%	-$153K	0.04%	348
2013 Q4	$10.7M	Buy	148,680 +12,382	+9%	+$861K	0.04%	359
2013 Q3	$9.37M	Sell	136,298 -9,253	-6%	-$612K	0.04%	369
2013 Q2	$9.22M	Buy	+145,551	New	+$9.47M	0.04%	360

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Suntrust Banks's NVS Position: Q3 2019 in Review

Suntrust Banks increased its Novartis (NVS) stake by 361% in Q3 2019, buying an estimated $21.4M and bringing the position to 303,719 shares worth $26.4M. The position accounts for 0.14% of the portfolio, ranked #132.

Suntrust Banks first reported a position in NVS in Q2 2013 and has held it in 26 quarters since. 1,091 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

Suntrust Banks held 303,719 shares of Novartis worth $26.4M as of Q3 2019.
Suntrust Banks bought 237,814 Novartis shares in Q3 2019, an estimated $21.4M.
Novartis made up 0.14% of Suntrust Banks's portfolio in Q3 2019, its #132 holding.
Suntrust Banks first reported a position in Novartis in Q2 2013 and has held it in 26 quarters since.
1,091 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.